Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
RESEARCH TOOLSreports
Holding PHAT?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 16, 2024 | Asit Parikh Director | xxxxxxxxxxxxx | $81200 |
| Dec 16, 2024 | Frank Karbe Director | xxxxxxxxxxxxx | $99000 |
| Apr 10, 2024 | Molly Henderson Cfo And Cbo | xxxxxxxxxxxxx | $38129 |
| Jan 25, 2024 | Takeda Pharmaceutical Co Ltd >10% Owner | xxxxxxxxxxxxx | $29999994 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $2350400 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $13550724 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $29341724 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $46527288 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,863,424 | Insider | 8.58% | 46,262,415 | |
| 3,755,583 | Insider | 5.49% | 29,631,550 | |
| 2,623,427 | Institution | 3.84% | 20,698,839 | |
| 2,573,412 | Institution | 3.76% | 20,304,221 | |
| 2,202,267 | Institution | 3.22% | 17,375,887 | |
| 2,023,941 | Institution | 2.96% | 15,968,894 | |
| 1,972,750 | Institution | 2.89% | 15,564,998 | |
| 1,622,883 | Institution | 2.37% | 12,804,547 | |
| 1,231,255 | Insider | 1.80% | 9,714,602 | |
| 1,029,699 | Insider | 1.51% | 8,124,325 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,202,267 | Institution | 3.22% | 17,375,887 | |
| 1,972,750 | Institution | 2.89% | 15,564,998 | |
| 862,554 | Institution | 1.26% | 6,805,551 | |
| 746,710 | Institution | 1.09% | 5,891,542 | |
| 464,839 | Institution | 0.68% | 3,667,580 | |
| 391,953 | Institution | 0.57% | 3,092,509 | |
| 385,025 | Institution | 0.56% | 3,037,847 | |
| 249,398 | Institution | 0.36% | 1,967,750 | |
| 227,003 | Institution | 0.33% | 1,791,054 | |
| 226,490 | Institution | 0.33% | 1,787,006 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,648,719 | Institution | 2.41% | 28,275,531 | |
| 554,001 | Institution | 0.81% | 9,501,117 | |
| 982,329 | Institution | 1.44% | 7,750,576 | |
| 521,935 | Institution | 0.76% | 4,118,067 | |
| 155,907 | Institution | 0.23% | 2,673,805 | |
| 124,854 | Institution | 0.18% | 2,141,246 | |
| 258,089 | Institution | 0.38% | 2,036,322 | |
| 220,480 | Institution | 0.32% | 1,739,587 | |
| 205,037 | Institution | 0.30% | 1,617,742 | |
| 173,956 | Institution | 0.25% | 1,389,039 |
FAQ
Who Owns Phathom Pharmaceuticals (PHAT)?
Currently, no data Available
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
Currently, no data Available
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.